Human protein phosphatase 2C

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Incyte Corporation patent solves the following problem:

Change protein phosphorylation is ubiquitous methods used to control many of intracellular events in eukaryotic cells. It is estimated that more than ten percent of the active protein in a typical mammal cell are phosphorylated. Kinases to facilitate the transfer of high-energy phosphate group from adenosine triphosphate (ATP) to the target protein hydroxyamino acid residues serine, threonine, or tyrosine. Phosphatases, in contrast, take the phosphate groups. Extracellular signal including the hormone, neurotransmitter, growth and inequality factors may activate kinases, which takes place as the cell surface of cells or as activator in the final effector proteins, as well as other places along the way signal transduction. Cascade of kinases occur, as well as sensitive kinases second messenger molecules. This system allows for equipment to amplify the weak signal (lower abundance of growth factor molecules, for example), as well as the synthesis of many weak signal into an all-or-nothing answer. Phosphatases, then, is necessary to determine the extent of phosphorylation in cells and, with kinases, controlling key cellular processes such as metabolic enzyme activity, proliferation, cell growth and inequality, cell adhesion, and cell cycle progression.

Our analysis of this patent is as follows:

Incyte Corporation’s patent US 7029897 B2 deals with Human protein phosphatase 2C.
invention provides human kinases and phosphatases (KAP) and polnucleotides to recognize and encode KAP. invention also provides expresson vector, host cells, antibodies, agonists and antagonists. invention also provides methods for diagnosing, treating, or preventing diseases associated with aberrant expression of KAP.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Information recording/displaying card

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Minolta Co., Ltd. patent solves the following problem:

The present invention relates to an information recording / display card. Particularly, it relates to an information recording / display card containing an invisible information recording part and a visible information display part information written under predetermined heating conditions and written information can be erased, and an information recording / display system using the card.

Our analysis of this patent is as follows:

Minolta Co., Ltd.’s patent US 6580481 B2 deals with Information recording/displaying card.
the invention provides an information recording / displaying card information and a recording / display system using cards that invisible information will be recorded, so that the information can be displayed as view information and see information can be written / erased as color images in a practical speed. The information recording / display card includes a visible display of information and an invisible information recording part. These parts would, for example, the front and back of the card, respectively, or arranged side by side in the front or the back face. The visible information display part includes, as a main part, a low molecular weight cholesteric liquid crystal compound having an isotropic phase transition temperature higher than a melting point, such information will be shown, once written and laid therein. The invisible information recording part, for example, a magnetic recording layer, a write-once optical recording layer of an integrated circuit memory, information can be recorded and erased.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Mammalian imidazoline receptor

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Incyte Genomics, Inc. patent solves the following problem:

Phylogenetic relationships among organisms shown many times, and studies from a diversity of prokaryotic and eukaryotic organisms suggest a more or less gradual evolution in biochemical and physiological mechanisms and metabolic pathways . Despite the different evolutionary pressures, the proteins that control the cell cycle in yeast, nematode, flies, mice, and humans have common chemical and structural parts and modulate the same general movement. Comparing human gene sequences from other organisms which structure and / or function known allow researchers to draw analogies, and developing model systems for testing diagnostic and therapeutic agents for the human condition, diseases, and disorders.

Our analysis of this patent is as follows:

Incyte Genomics, Inc.’s patent US 6475752 B1 deals with Mammalian imidazoline receptor.
The present invention is a mammal nucleic acid molecules and fragments thereof. It also provides for the use of mammal nucleic acid molecules for the characterization, diagnosis, evaluation, treatment, or prevention of conditions, diseases and disorders associated with the expression and production for a model system. the invention further provides expression vector and host cells for production of proteins encoded in the mammalian nucleic acid molecule. the invention further provides a mammal proteins or portions thereof. the invention further provides for the use of nucleic acid molecules and proteins in assays to detect or purify ligands.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Anti-regurgitation infant formula

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Bristol-Myers Squibb Company patent solves the following problem:

Starch is composed of two distinct polymer fractions: amylose and amylopectin. Amylose is the linear particle containing -1.4 linked glucose units. Amylopectin has the same structure as amylose but some of the glucose units combined with a -1.6 relationship giving rise to a branched structure. Flour generally contain 17-24% amylose and from 76-83% amylopectin.

Our analysis of this patent is as follows:

Bristol-Myers Squibb Company’s patent US 6099871 A deals with Anti-regurgitation infant formula.
Infant formulas containing certain thickening agents useful for the treatment of regurgitation. The thickening agent may waxy maize starch, waxy rice starch, or a mixture thereof.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Lactobacillus sake like strains, production and use of their exopolysaccharides

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Quest International B.V. patent solves the following problem:

A large number of food products such as mayonnaises, dressings, margarines, spreads or low-fat or zero-fat alternative, be stabilized by polysaccharides as emulsion stabilizers or thickening agents. Also in the medical, pharmaceutical and cosmetic fields, polysaccharides used as emulsion stabilizers. Well known polysaccharides derived from a variety of plant seeds, for example guar gum from cyamopsis tetragonaloba (guar), or locust bean gum (LBG) from locust bean. The other well known sources are seaweeds, giving carrageenan, alginates or agar.

Our analysis of this patent is as follows:

Quest International B.V.’s patent US 5834043 A deals with Lactobacillus sake like strains, production and use of their exopolysaccharides.
New Lactobacillus sake like the kind given product from the meat, the kind to make a exopolysaccharide with shear-thinning properties, even at low concentration, and / or thickening and / or emulsion-strengthening properties.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method of controlling transmission of defects

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Mainframe Data Limited patent solves the following problem:

Our analysis of this patent is as follows:

Mainframe Data Limited’s patent US 5108131 A deals with Method of controlling transmission of defects.
Tools useful in preventing or reducing the risk of transmission of an infectious disease, AIDS, disease or gene, comprising recognition means as a personal card details giving birth to a first participants and security component (s) and a storage medium such as a certificate or a data base, which carries the read or retreivable test result data about the particular defect. The second contestant to consult the results by allowing close contact or accept a donation of blood, body tissue or similar material.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Patient identification system

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Shamos Morris H patent solves the following problem:

The present invention relates to the field of patient identification, especially the methods, devices and systems to strengthen the identity of a person to receive a treatment with the patients for whom the treatment is intended.

Our analysis of this patent is as follows:

Shamos Morris H’s patent US 5071168 A deals with Patient identification system.
States is a way to strengthen the identity of a patient in a man receiving a treatment for said patients, by (a) obtaining a print identification characteristics of said patient; (B) to obtain a print identification characteristic of said individual to whom the treatment is intended to be administered; (C) has confirmed the birth to print identification characteristics obtained from patients with print identification characteristics derived from the individual. Also disclosed that a fighting devices and systems. The device information will identify one or more than one patient.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Process for control of microorganisms with phosphorus-based compositions

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Bromine Compounds Ltd. patent solves the following problem:

The present invention relates to compositions useful as biocides for controlling harmful microorganisms. Especially the invention relates to phosphorus-based composition containing rare biocidical properties for a broad spectrum of applications.

Our analysis of this patent is as follows:

Bromine Compounds Ltd.’s patent US 5025002 A deals with Process for control of microorganisms with phosphorus-based compositions.
Phosphorus-based compositions useful as biocides for controlling a broad spectrum of harmful micoorganisms expressed. The composition includes at least one compound of general formula (RO) 2 P (O) CXYZ where R is H, a C1-12 aliphatic hydrocarbon radical or a phenyl radical, X is H or halogen Y is halogen, and Z is a substitutent selected from the group consisting of COOH, CN, COOR and CONR2, with the proviso that X and I can not be in two C1. The effective concentration of the biocides vary according to the specific system, generally in the range of between 0.1 to 5000 parts per million of the substrate. The composition can be used alone or in the form of mixtures with other known compatible active agents. The compositions show high biocidal activity against various microorganisms compared with known biocides.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Combination medical data, identification and health insurance card

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Brown Steven P patent solves the following problem:

This invention relates to a combination of medical information, knowledge and health insurance card, and especially, a card can be carried in a purse or pocket, and comprising a substantially bug -Its medical history and other data about the take.

Our analysis of this patent is as follows:

Brown Steven P’s patent US 4632428 A deals with Combination medical data, identification and health insurance card.
A mechanical eye and read medical information, knowledge and health insurance card provides two "leaves", each of which has two faces on to see the data. The leaves, card-like member, connected to a self-hinge, and can be folded with respect to each other or lying flat. data includes sight-read material on the card as well as a microfilm strip associated with the card, and also machine-readable indicia such as medical history to take, including, if so desired, an electro- cardiogram.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.